1027708-39-9

Upstream product

• 3973-08-8 Thiazole-4-carboxylic acid 
• 214360-73-3 4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)aniline 

Downstream Products

• 1609271-85-3 C₂₂H₂₀BrN₅O₂S 
• 1609271-86-4 C₂₂H₁₆F₃N₅O₂S 
• 1609270-31-6 C₂₂H₁₈F₃N₅O₂S 
• 1609270-72-5 C₂₉H₂₄F₃N₅O₂S 
• 1609271-71-7 C₁₄H₁₁BrN₄OS 
• 1609271-70-6 C₁₄H₁₁BrN₄OS 

Relevant academic research and scientific papers

INHIBITORS OF CYTOMEGALOVIRUS

Compounds of Formula (I) wherein n, R1, R1A, R2, R3, Y and Z are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.

INHIBITORS OF HEPATITIS C VIRUS POLYMERASE

The present invention provides, among other things, compounds represented by the general Formula (I) and pharmaceutically acceptable salts thereof, wherein X, Y, R1A, R1B, R2, and R3 are as defined in classes and subclasses herein and compositions (e.g., pharmaceutical compositions) comprising such compounds, which compounds are useful as inhibitors of hepatitis C virus polymerase, and thus are useful, for example, as medicaments for the treatment of HCV infection.

2-CARBOXY THIOPHENE DERIVATIVES AS ANTI VIRAL AGENTS

Anti-viral agents of compounds of Formula (I): wherein A, R1, R2 and R3 are as defined in the specification, processes for their preparation and their use in HCV treatment are provided.